Hematologist
CION Cancer Clinics
POD24: what early progression in follicular lymphoma means | CION Cancer Clinics
POD24 means your follicular lymphoma started growing again within twenty-four months of beginning your first chemoimmunotherapy. It tells your haematologist the lymphoma is more stubborn than usual, so a fresh biopsy and a different kind of treatment are normally planned. It does not tell you how long you have, and it does not mean nothing can be done. This page explains the term, the next steps and the questions to ask. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does POD24 mean on a follicular lymphoma report?
- What does POD24 tell your team, and what does it not?
- How is early progression different from later progression?
- What usually happens once early progression is suspected?
- Which words around POD24 will you see?
- What options are discussed after early progression?
- What do families believe about POD24, and what is true?
- Common questions about POD24 in follicular lymphoma
The short answer
What does POD24 mean on a follicular lymphoma report?
POD24 stands for progression of disease within twenty-four months. It means the follicular lymphoma started growing again within two years of starting the first course of chemoimmunotherapy, which is chemotherapy given together with an antibody medicine such as rituximab.
Why doctors single it out
Most people with follicular lymphoma have long stretches of calm after their first treatment. A smaller group sees the lymphoma return early. Research has shown that this early group tends to have a more stubborn illness, so the label tells your haematologist to look more closely and plan the next step with extra care.
When the clock starts
The two years are counted from the start of that first chemoimmunotherapy. They are not counted from the day of diagnosis. Time spent on watch and wait, before any treatment, does not count. If you only had rituximab on its own, or only radiotherapy, the term is not usually applied in the same way, so ask your team whether it fits your history at all.
POD24 describes what has happened so far. It is not a prediction written for you personally.Reading the label
What does POD24 tell your team, and what does it not?
The label changes how carefully the next plan is made. It does not decide the plan on its own.
It asks for a fresh biopsy
Early return can sometimes mean the lymphoma has changed into a faster type. A new sample of tissue is the only way to check this properly.
It points away from repeating the same treatment
If a treatment held the lymphoma back for a short time only, teams usually look for a different kind of treatment next rather than giving the same one again.
It does not tell you how long you have
On average the outlook is more guarded, but averages hide a very wide spread. Many people in this group respond well to the next treatment.
It does not mean something was missed
Early progression is a feature of the lymphoma's own behaviour. It is rarely caused by a wrong choice of first treatment or by anything you did.
Things that do not cause it
- Diet or food choices
- Stress or worry
- Travelling for treatment
Not sure whether this applies to you?
Ask an oncologistSide by side
How is early progression different from later progression?
Early (POD24)
Later progression
Lymphoma grows again within two years of starting chemoimmunotherapy
Lymphoma stays calm for longer before it returns
A repeat biopsy is strongly advised to look for change
A biopsy is still often advised, especially with new symptoms
A different kind of treatment is usually chosen
Watch and wait, or a similar treatment, may be reasonable again
Referral for advanced options is discussed early
Advanced options are usually kept in reserve for later
The next few weeks
What usually happens once early progression is suspected?
A scan to map the disease
A PET-CT, a scan that shows which areas are active, helps show where the lymphoma is growing and which lymph node is the most active. That node is often the right place to take a sample from.
A new biopsy
A surgeon or radiologist removes a lymph node or a core of tissue. The pathologist checks whether it is still follicular lymphoma or has changed into a faster-growing large cell lymphoma.
Blood tests and a fitness check
Blood counts, kidney and liver tests, and a look at your heart and general strength. These decide which treatments are safe for you, not only which ones work.
The plan is discussed together
At CION the case goes to a tumour board, where several specialists agree the plan. You and your family then hear what is advised, what the other choices were, and why.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
Which words around POD24 will you see?
- Progression
- The lymphoma is growing, on a scan or in how you feel, after a period when it was held back.
- Relapse
- The lymphoma has come back after it had shrunk away or become very small with treatment.
- Refractory
- The lymphoma did not respond to a treatment, or grew while you were still receiving it.
- Transformation
- A slow lymphoma has changed into a faster-growing type, most often diffuse large B-cell lymphoma. It needs different treatment.
- Chemoimmunotherapy
- Chemotherapy given together with an antibody medicine, such as rituximab or obinutuzumab, that sticks to lymphoma cells.
- Second line
- The treatment given after the first one has stopped working.
Treatment after POD24
What options are discussed after early progression?
The next treatment depends on the biopsy result, what you had before, your age and your fitness. If the lymphoma has transformed, it is treated as a faster lymphoma. If it has not, the choices usually include a different chemoimmunotherapy, lenalidomide with rituximab, or one of the newer antibody medicines that help your own immune cells find the lymphoma.
Stronger options, and who they suit
For some younger and fitter people, a stem cell transplant using your own cells, or CAR-T cell therapy, is discussed. These are demanding treatments done at specialist centres. They do not suit people who are frail, have serious heart, lung or kidney problems, or whose lymphoma is not responding at all. CION's haematology team does not perform these in-house. It assesses whether you may be suitable and coordinates referral with qualified centres.
What this page cannot tell you
No page can tell you which treatment is right for you or how well it will work. Those answers come from your own biopsy, scans and health. Clinical trials are also worth asking about, because early progression is an area where research is active.
Do not stop or change any medicine on your own while waiting for results. Your treating team sets every change.Commonly believed
What do families believe about POD24, and what is true?
"The first treatment failed, so treatment does not work for him."
A short response to one treatment says little about the next. Treatments after POD24 work in different ways, and many people respond well to them. The label is a reason to plan carefully, not a reason to give up on treatment.
"We should have chosen a different hospital the first time."
Early progression comes mainly from how the lymphoma behaves. It happens even when first treatment follows international guidelines exactly. Guilt uses energy the family needs for the next step.
"A new biopsy is unnecessary. We already know it is lymphoma."
The question now is what kind of lymphoma it has become. If it has transformed, the treatment is quite different. Skipping the biopsy can mean giving the wrong treatment.
"POD24 means the illness is now untreatable."
It means the lymphoma is harder to control, on average. It does not mean nothing can be done. Several treatment routes remain, and your haematologist will explain which of them fit you.
Questions we are asked
Common questions about POD24 in follicular lymphoma
Is POD24 the same as the lymphoma coming back?
It is a specific kind of coming back. POD24 is used only when the lymphoma grows again within two years of starting first chemoimmunotherapy. A return after a longer calm period is still called progression or relapse, but it does not carry the POD24 label or the same level of concern.
Does POD24 mean the lymphoma has turned aggressive?
Not necessarily. Some people with POD24 still have slow follicular lymphoma that simply did not stay controlled for long. Others have had a transformation into a faster type. Only a fresh biopsy can tell the difference, which is why your team will usually ask for one before deciding anything.
Could we have known at diagnosis that this would happen?
Not reliably. Scoring systems such as FLIPI and some research tests give a rough idea of who is at higher risk. None of them can say in advance which person will progress early. Most people labelled high risk at diagnosis do not go on to have POD24.
Should we get a second opinion?
It is reasonable, especially before a stem cell transplant or CAR-T cell therapy is decided. Bring every biopsy report, scan and treatment summary, with dates. A haematologist reading the full history can check whether POD24 really applies and which options suit you. A good treating team will not be upset that you asked.
What symptoms suggest the lymphoma is growing again?
New or enlarging lumps in the neck, armpit or groin, drenching night sweats, unexplained fevers, weight loss, or new pain in the tummy or back. Tell your team soon rather than waiting for the next routine visit. Rapid growth of one lump, or feeling very unwell, needs a quicker review.
Is CAR-T cell therapy available for this in India?
CAR-T cell therapy is offered at a limited number of specialist centres in India, and eligibility rules differ. CION does not give it in-house. The haematology team can assess whether you may be suitable, and help you understand what to ask a treating centre about timing, travel and cost.
Will insurance or Aarogyasri cover treatment after POD24?
Many standard treatments are covered by Aarogyasri, PM-JAY, CGHS, ECHS, EHS or cashless insurance when they are part of an approved plan. Newer medicines and cell therapies may be covered only partly. Scheme rules change, so check the current rules with your scheme or insurer before treatment starts.
How do we explain POD24 to my father without frightening him?
Start with what is happening next, not with the label. Say the lymphoma has become active again and the doctors are checking it carefully before choosing a new treatment. Most people cope better with clear, honest news given with family present. Our team can sit with you for that conversation.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — B-Cell Non-Hodgkin Lymphoma Treatment (PDQ), Health Professional Version
- Leukemia & Lymphoma Society — Non-Hodgkin lymphoma
- Cancer Research UK — Non-Hodgkin lymphoma
- American Cancer Society — Non-Hodgkin lymphoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Been told the lymphoma is back early?
Share your reports with us. CION's haematology team will review them, explain what POD24 means for you and help plan the next step. One helpline serves every CION centre.